Title

Phase 1 Trial of Tucatinib, Trastuzumab, and Capecitabine With Stereotactic Radiosurgery in Patients With Brain Metastases From HER-2 Positive Breast Cancer

Publication Date

6-2-2023

Presented At:

ASCO Annual Meeting

Content Type

Poster Presentation

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS